The ORCHID Study
Ovarian Cancer Epidemiology, Healthcare Access and Disparities Study
In the United States, less than 40% of ovarian cancer patients receive the standard of care for surgery and chemotherapy. Black patients are even less likely to receive this care in comparison to their White counterparts. Racial differences in ovarian cancer care and outcomes is largely due to differences in healthcare access.
The purpose of our study is to evaluate the different dimensions of healthcare access among Black, White, and Hispanic study participants: availability, affordability, accessibility, accommodation and acceptability of health care services.
With the results of this study, we hope to better understand the nature of racial disparities, assess the importance of race-specific barriers to care, and find ways to address these barriers in order to improve ovarian cancer care for all patients.
ORCHiD Study Schema
The figure to the right shows the schema or outline for the ORCHiD study. We utilized focus groups and cognitive interviews to create our primary cohort or first set of data. Then we used a data registry to create a secondary cohort or second set of data. With this data, we assessed the HCA dimensions, socio-demographic/epidemiological risk factors, and obtained biospecimens. We used these factors to determine if treatment met guidelines, and what survival outcomes were in each group. With these results, we hope to find ways to improve ovarian cancer outcomes for all patients.
